Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Clinical Genitourinary Cancer
|
June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer
Todd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
The Journal of Urology
|
November 5, 2016
Urinary Diversion for Severe Urinary Adverse Events of Prostate Radiation: Results from a Multi-Institutional Study
Mitchell R Bassett, Yahir Santiago-Lastra, John T Stoffel, et al.
BJU International
|
April 28, 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration
Praful Ravi, Gregory R Pond, Leonidas N Diamantopoulos, et al.
Research Square
|
May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
NEJM Evidence
|
February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Sagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology
|
May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Rebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA Oncology
|
January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
Amar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Clinical Genitourinary Cancer
|
June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer
Todd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
The Journal of Urology
|
November 5, 2016
Urinary Diversion for Severe Urinary Adverse Events of Prostate Radiation: Results from a Multi-Institutional Study
Mitchell R Bassett, Yahir Santiago-Lastra, John T Stoffel, et al.
BJU International
|
April 28, 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration
Praful Ravi, Gregory R Pond, Leonidas N Diamantopoulos, et al.
Research Square
|
May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
NEJM Evidence
|
February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
Daniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Sagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology
|
May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Rebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA Oncology
|
January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
Amar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open
|
July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Page
of 8